TransMedics, headquartered in Andover, Mass., is a medical technology company that offers transplant services, including its Organ Care System (OCS), a portable organ preservation system that ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates ...

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Bernstein Liebhard LLP:Do you, or did you, own shares of TransMedics Group, Inc.

TransMedics Group Inc (NASDAQ:TMDX) reported a strong Q4 2024 with total revenue of $121.6 million, representing approximately 50% growth year over year. The company's US revenue grew 11% ...

TransMedics (TMDX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.12 per share a year ago.

Despite a Q3 earnings miss and short-seller allegations, TMDX has shown remarkable five-year growth and operational advantages. TMDX's market share in heart, liver, and lung transplants has ...

The complaint alleges that TransMedics made false and misleading statements, while failing to disclose crucial information. Specifically, the suit contends that TransMedics used kickbacks ...